Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma:: a case control study

被引:96
|
作者
Massi, D
Puig, S
Franchi, A
Malvehy, J
Vidal-Sicart, S
González-Cao, M
Baroni, G
Ketabchi, S
Palou, J
Santucci, M
机构
[1] Univ Florence, Dipartimento Patol Umana & Oncol, I-50134 Florence, Italy
[2] Hosp Clin Barcelona, Dept Dermatol, E-08036 Barcelona, Spain
[3] Hosp Clin Barcelona, Dept Nucl Med, E-08036 Barcelona, Spain
[4] Hosp Clin Barcelona, Dept Oncol, E-08036 Barcelona, Spain
关键词
D O I
10.1136/jcp.2005.028431
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: Cutaneous melanoma spreads preferentially through the lymphatic route and sentinel lymph node (SLN) status is regarded as the most important predictor of survival. Aims: To evaluate whether tumour lymphangiogenesis and the expression of vascular endothelial growth factor C (VEGF-C) is related to the risk of SLN metastasis and to clinical outcome in a case-control series of patients with melanoma. Methods: Forty five invasive melanoma specimens ( 15 cases and 30 matched controls) were investigated by immunostaining for the lymphatic endothelial marker D2-40 and for VEGF-C. Lymphangiogenesis was measured using computer assisted morphometric analysis. Results: Peritumorous lymphatic vessels were more numerous, had larger average size, and greater relative area than intratumorous lymphatics. The number and area of peritumorous and intratumorous lymphatics was significantly higher in melanomas associated with SLN metastasis than in non-metastatic melanomas. No significant difference in VEGF-C expression by neoplastic cells was shown between metastatic and non-metastatic melanomas. Using logistic regression analysis, intratumorous lymphatic vessel (LV) area was the most significant predictor of SLN metastasis (p=0.04). Using multivariate analysis, peritumorous LV density was an independent variable affecting overall survival, whereas the intratumorous LV area approached significance (p=0.07). Conclusions: This study provides evidence that the presence of high peritumorous and intratumorous lymphatic microvessel density is associated with SLN metastasis and shorter survival. The intratumorous lymphatic vessel area is the most significant factor predicting SLN metastasis. The tumour associated lymphatic network constitutes a potential criterion in the selection of high risk patients for complementary treatment and a new target for antimelanoma therapeutic strategies.
引用
收藏
页码:166 / 173
页数:8
相关论文
共 50 条
  • [41] Sentinel lymph node biopsy in pediatric and adolescent cutaneous melanoma
    Howman-Giles, Robert
    Shaw, Helen
    Scolyer, Richard
    Uren, Roger
    Thompson, John
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [42] Trends in Sentinel Lymph Node Biopsy Enactment for Cutaneous Melanoma
    Mary-Ann El Sharouni
    Arjen J. Witkamp
    Vigfús Sigurdsson
    Paul J. van Diest
    [J]. Annals of Surgical Oncology, 2019, 26 : 1494 - 1502
  • [43] Sentinel Lymph Node Biopsy in Head and Neck Cutaneous Melanoma
    Patuzzo, R.
    Maurichi, A.
    Camerini, T.
    Gallino, G.
    Ruggeri, R.
    Mattavelli, I
    Crippa, F.
    Moglia, D.
    Tolomio, E.
    Maccauro, M.
    Santinami, M.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 52 - 53
  • [44] Author Reply: Sentinel Lymph Node Biopsy in Cutaneous Melanoma
    Ilkka Koskivuo
    Lauri Talve
    Pia Vihinen
    Maija Mäki
    Tero Vahlberg
    Erkki Suominen
    [J]. Annals of Surgical Oncology, 2008, 15 : 1810 - 1811
  • [45] Sentinel Lymph Node Biopsy for Patients With Cutaneous Desmoplastic Melanoma
    David E. Gyorki
    Klaus Busam
    Kathy Panageas
    Mary Sue Brady
    Daniel G. Coit
    [J]. Annals of Surgical Oncology, 2003, 10 : 403 - 407
  • [46] Trends in Sentinel Lymph Node Biopsy Enactment for Cutaneous Melanoma
    El Sharouni, Mary-Ann
    Witkamp, Arjen J.
    Sigurdsson, Vigfus
    van Diest, Paul J.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (05) : 1494 - 1502
  • [47] Contraindications to sentinel lymph node biopsy in cutaneous malignant melanoma
    Lloyd, MS
    Topping, A
    Allan, R
    Powell, B
    [J]. BRITISH JOURNAL OF PLASTIC SURGERY, 2004, 57 (08): : 725 - 727
  • [48] Sentinel node biopsy in cutaneous melanoma:: Correlations between melanoma prognostic factors and sentinel node status
    Minutilli, E.
    Giannarelli, D.
    Anza, M.
    Garinei, R.
    Perri, P.
    Botti, C.
    Piarulli, L.
    Bruno, P.
    Rea, S.
    Visca, P.
    Mottolese, M.
    Di Filippo, S.
    Di Filippo, F.
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2007, 26 (01) : 71 - 76
  • [49] Radioguided sentinel lymph node biopsy in malignant cutaneous melanoma
    Mariani, G
    Gipponi, M
    Moresco, L
    Villa, G
    Bartolomei, M
    Mazzarol, G
    Bagnara, MC
    Romanini, A
    Cafiero, F
    Paganelli, G
    Strauss, HW
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (06): : 811 - 827
  • [50] Sentinel lymph node biopsy for patients with cutaneous desmoplastic melanoma
    Gyorki, DE
    Busam, K
    Panageas, K
    Brady, MS
    Coit, DG
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (04) : 403 - 407